Editorial policy

Sources

VigiEye reports from primary records only: medicines regulators (EMA, FDA, MHRA and the national competent authorities), the European Commission and official journals, courts and enforcement agencies, and company filings with the SEC. Each story names and links its source. We do not rewrite other publications' articles and we do not link to trade press.

Use of AI tools

We use AI language models (Anthropic's Claude) to read the source documents and draft the stories, analyses and opinion pieces in our own words, following written instructions on accuracy, attribution and tone. Figures, dates and names come from the source record that the story links to. The editorial process, its rules and the choice of what we publish are the responsibility of the publisher, PQRA, the regulatory, quality and pharmacovigilance consultancy of Dimitrios Gkikas.

Analysis and opinion

Pieces labelled Analysis explain a development and its context. Pieces labelled Opinion or View state the site's argued view. Neither is investment, medical or legal advice.

Corrections

If something is wrong, write to info@pqra.gr with the page address. We check against the official source and correct promptly.

Independence and conflicts of interest

VigiEye and PQRA have the same owner, and PQRA's services are promoted in labelled house advertisements. Companies do not pay for coverage, and we do not publish sponsored stories.